From 2005-2011, 27.8% of all patients recruited for clinical trials came from North America and the United States. Asia supplied 9.3% of all patients accounting for 83,599. This was an average of 17 patients per trial site.
In a report from Scrip Asia 100, they look at Asia by the most important countries for clinical trials. The other countries in Asia that have the most patients in clinical trials include India - who contributed 1.9% of patients, Australia who contributed 1.3% of patients and the Philippines who contributed 1.2% of all patients. The authors emphasize that companies looking to lean on clinical trial recruitment in the region must be aware of each country and be conscious of their cultural norms. Download the full report here.
This September at Partnerships in Clinical Trials Asia, Yanping Zheng, Director, Clinical ffairs/Medical Monitor, Mallinckrodt Pharmaceuticals, USA will join us in Shanghai to deliver the presentation Quality not Just Quantity: How to Create a Patient Recruitment Plan during Study Startup. She will examine many of the issues and cultural normal set forth in the white paper. Download the agenda to find out more about the session and the rest of the program. Would you like to join Yanping Zheng September 16-18 in Shanghai? As a reader of this blog, when you register to join us and mention code XP1975BLOG, you can save 20% off the standard rate! Have any questions or want to get involved? Email Jennifer Pereira.
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to email@example.com.